The Department of Health's failure to propose ongoing and regular reporting or consultation mechanisms for new PBS cost-recovery arrangements stands in stark contrast with its own medicine regulator and other federal government agencies.
Latest Video
New Stories
-
New roadmap launched to support Australians living with aggressive lymphomas
September 16, 2025 - - Latest News -
Lilly Australia announces leadership transition as Tori Brown moves to global role
September 16, 2025 - - Latest News -
Decision-making at its nadir, exposing the cruelty of incoherence
September 16, 2025 - - Latest News -
Use of antipsychotic twice as high in aged care residents with dementia
September 15, 2025 - - Latest News -
Australian discovery advances to global Phase 3 breast cancer trial with Pfizer
September 15, 2025 - - Latest News -
Alterity Therapeutics delivers promising Phase 2 data in Multiple System Atrophy
September 15, 2025 - - Australian Biotech -
Actinogen secures FDA agreement to advance Xanamem for Alzheimer’s disease
September 15, 2025 - - Australian Biotech